Cargando…

Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data

Triflumezopyrim, a novel mesoionic insecticide used to control planthoppers, is a potential substitute for imidacloprid. In this study, triflumezopyrim and imidacloprid residues in rice were determined using a quick, easy, cheap, effective, rugged, and safe procedure combined with ultra-high-perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Wang, Meiran, Silipunyo, Thiphavanh, Huang, Haizhu, Yin, Qingchun, Han, Bingjun, Wang, Mingyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458175/
https://www.ncbi.nlm.nih.gov/pubmed/36080451
http://dx.doi.org/10.3390/molecules27175685
_version_ 1784786237494657024
author Zhang, Yue
Wang, Meiran
Silipunyo, Thiphavanh
Huang, Haizhu
Yin, Qingchun
Han, Bingjun
Wang, Mingyue
author_facet Zhang, Yue
Wang, Meiran
Silipunyo, Thiphavanh
Huang, Haizhu
Yin, Qingchun
Han, Bingjun
Wang, Mingyue
author_sort Zhang, Yue
collection PubMed
description Triflumezopyrim, a novel mesoionic insecticide used to control planthoppers, is a potential substitute for imidacloprid. In this study, triflumezopyrim and imidacloprid residues in rice were determined using a quick, easy, cheap, effective, rugged, and safe procedure combined with ultra-high-performance liquid chromatography–tandem mass spectrometry. The limit of quantification of both triflumezopyrim and imidacloprid was 0.01 mg kg(−1), and the average recovery values were 94–104% and 91–106%, with relative standard deviations (RSDs) of 1.1–1.4% and 2.1–3.4% (n = 5), respectively. The consumer protection level was assessed by calculating the theoretical maximum daily intake using the reported maximum residue limits of triflumezopyrim and imidacloprid. The established method was successfully applied to 200 commercial rice samples collected from four provinces in China, and their potential public health risks were assessed using triflumezopyrim and imidacloprid residues. The risk associated with triflumezopyrim and imidacloprid dietary intake was assessed by calculating the national estimated short-term intake and the acute reference dose percentage (%ARfD). The results show that the theoretical maximum daily intake (NEDI) values of triflumezopyrim and imidacloprid in different age and gender groups were 0.219–0.543 and 0.377–0.935 μg kg(−1) d(−1) bw, and the risk quotient (RQ) values were 0.188–0.467% and 0.365–0.906%, respectively. The acute reference dose (%ARfD) of triflumezopyrim and imidaclopridin ranged from 0.615 to 0.998% and from 0.481 to 0.780%, respectively.
format Online
Article
Text
id pubmed-9458175
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94581752022-09-09 Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data Zhang, Yue Wang, Meiran Silipunyo, Thiphavanh Huang, Haizhu Yin, Qingchun Han, Bingjun Wang, Mingyue Molecules Article Triflumezopyrim, a novel mesoionic insecticide used to control planthoppers, is a potential substitute for imidacloprid. In this study, triflumezopyrim and imidacloprid residues in rice were determined using a quick, easy, cheap, effective, rugged, and safe procedure combined with ultra-high-performance liquid chromatography–tandem mass spectrometry. The limit of quantification of both triflumezopyrim and imidacloprid was 0.01 mg kg(−1), and the average recovery values were 94–104% and 91–106%, with relative standard deviations (RSDs) of 1.1–1.4% and 2.1–3.4% (n = 5), respectively. The consumer protection level was assessed by calculating the theoretical maximum daily intake using the reported maximum residue limits of triflumezopyrim and imidacloprid. The established method was successfully applied to 200 commercial rice samples collected from four provinces in China, and their potential public health risks were assessed using triflumezopyrim and imidacloprid residues. The risk associated with triflumezopyrim and imidacloprid dietary intake was assessed by calculating the national estimated short-term intake and the acute reference dose percentage (%ARfD). The results show that the theoretical maximum daily intake (NEDI) values of triflumezopyrim and imidacloprid in different age and gender groups were 0.219–0.543 and 0.377–0.935 μg kg(−1) d(−1) bw, and the risk quotient (RQ) values were 0.188–0.467% and 0.365–0.906%, respectively. The acute reference dose (%ARfD) of triflumezopyrim and imidaclopridin ranged from 0.615 to 0.998% and from 0.481 to 0.780%, respectively. MDPI 2022-09-03 /pmc/articles/PMC9458175/ /pubmed/36080451 http://dx.doi.org/10.3390/molecules27175685 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Yue
Wang, Meiran
Silipunyo, Thiphavanh
Huang, Haizhu
Yin, Qingchun
Han, Bingjun
Wang, Mingyue
Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title_full Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title_fullStr Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title_full_unstemmed Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title_short Risk Assessment of Triflumezopyrim and Imidacloprid in Rice through an Evaluation of Residual Data
title_sort risk assessment of triflumezopyrim and imidacloprid in rice through an evaluation of residual data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458175/
https://www.ncbi.nlm.nih.gov/pubmed/36080451
http://dx.doi.org/10.3390/molecules27175685
work_keys_str_mv AT zhangyue riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT wangmeiran riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT silipunyothiphavanh riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT huanghaizhu riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT yinqingchun riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT hanbingjun riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata
AT wangmingyue riskassessmentoftriflumezopyrimandimidaclopridinricethroughanevaluationofresidualdata